Evidence map›Paper›PMID 26710170›Full record

ArticleBioengineered2016

Engineering low-temperature expression systems for heterologous production of cold-adapted enzymes.

Gro Elin Kjæreng Bjerga, Rahmi Lale, Adele Kim Williamson

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Cold Active Lipases: Biocatalytic Tools for Greener Technology.Applied biochemistry and biotechnology · 2021
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Gro Elin Kjæreng Bjergaa University of Tromsø, Norstruct, Department of Chemistry, Faculty of Science and Technology , Tromsø , Norway.
Rahmi Laleb Norwegian University of Science and Technology , Department of Biotechnology , Trondheim , Norway.
Adele Kim Williamsona University of Tromsø, Norstruct, Department of Chemistry, Faculty of Science and Technology , Tromsø , Norway.
UiT The Arctic University of Norway · NONorwegian University of Science and Technology · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Production of psychrophilic enzymes in the commonly used mesophilic expression systems is hampered by low intrinsic stability of the recombinant enzymes at the optimal host growth temperatures. Unless strategies for low-temperature expression are advanced, research on psychrophilic enzymes may end up being biased toward those that can be stably produced in commonly used mesophilic host systems. Two main strategies are currently being explored for the development of low-temperature expression in bacterial hosts: (i) low-temperature adaption of existing mesophilic expression systems, and (ii) development of new psychrophilic hosts. These developments include genetic engineering of the expression cassettes to optimize the promoter/operator systems that regulate heterologous expression. In this addendum we present our efforts in the development of such low-temperature expression systems, and speculate about future advancements in the field and potential applications.

Indexed as

Gene Expression Regulation, BacterialIndustrial MicrobiologyArctic RegionsBacterial ProteinsCold TemperatureMetabolic EngineeringProtein StabilityPseudoalteromonasPseudomonasRecombinant ProteinsTrichodermaBacterial ProteinsRecombinant ProteinsAraC/PBADcold-adaptedcspA promoterHeterologous expressionPseudomonaspsychrophilicT7 promoterT7 RNA polymeraseXylS/Pm

Identifiers

PMID26710170
PMCPMC4878266
OpenAlexW2206705062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.